IGF-1 interacts with its cognate receptor IGF1R on the surface of tumor cells to activate the phosphatidylinositol 3-kinase (PI3K) signaling pathway, subsequently resulting in tumor resistance and proliferation (137). Here, IGF1R is linked to neoplasm.